首页> 美国卫生研究院文献>ACS Medicinal Chemistry Letters >Rhodanine as a Potent Scaffold for the Developmentof Broad-Spectrum Metallo-β-lactamase Inhibitors
【2h】

Rhodanine as a Potent Scaffold for the Developmentof Broad-Spectrum Metallo-β-lactamase Inhibitors

机译:罗丹宁是发展的有力支架光谱的金属β-内酰胺酶抑制剂

代理获取
本网站仅为用户提供外文OA文献查询和代理获取服务,本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文,但由于OA文献来源多样且变更频繁,仍可能出现获取不到、文献不完整或与标题不符等情况,如果获取不到我们将提供退款服务。请知悉。

摘要

A series of rhodanines was constructed, their Z-configuration was confirmed by small molecule X-ray crystal structures, and their activity against metallo-β-lactamases (MβLs) was measured. The obtained 26 molecules and a thioenolate specifically inhibited the MβL L1 with an IC50 range of 0.02–1.7 μM, and compounds >2h–>m exhibited broad-spectrum inhibition of the MβLs NDM-1, VIM-2, ImiS, and L1 with IC50 values <16 μM. All inhibitors increased the antimicrobial effect of cefazolin against E. coli cells expressing L1, resulting in a 2–8-fold reduction in MIC. Docking studies suggested that the nitro (NDM-1, CphA, and L1) or carboxyl group (VIM-2) of >2l coordinates one or two Zn(II) ions, while the N-phenyl group of the inhibitor enhances its hydrophobic interaction with MβLs. These studies demonstrate that the diaryl-substituted rhodanines are good scaffolds for the design of future broad-spectrum inhibitors of MβLs.
机译:构造了一系列的罗丹丹,它们的Z-构型已通过小分子X射线晶体结构得到证实,并测定了它们对金属-β-内酰胺酶(MβLs)的活性。获得的26个分子和一种硫代烯酸酯专门抑制MβLL1,IC50范围为0.02–1.7μM,化合物> 2h – > m 对MβLsNDM表现出广谱抑制作用-1,VIM-2,ImiS和L1,IC50值小于16μM。所有抑制剂均增强了头孢唑林对表达L1的大肠杆菌细胞的抗菌作用,导致MIC降低2-8倍。对接研究表明> 2l 的硝基(NDM-1,CphA和L1)或羧基(VIM-2)配位一个或两个Zn(II)离子,而Nstrong的N-苯基该抑制剂增强了其与MβLs的疏水相互作用。这些研究表明,二芳基取代的罗丹宁类是设计未来MβLs广谱抑制剂的良好支架。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
代理获取

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号